Boston University
Glycopolymer biomaterials for stimulating and characterizing glial adaptive reprogramming
Abstract
dc:description.abstractInjury to the central nervous system (CNS) caused by pathophysiological conditions or neural device implantation triggers a complex, multicellular response that is required to repair the damaged neural tissue. Critically, endogenous glial cells, including microglia and astrocytes, must undergo adaptive reprogramming, abandoning homeostatic activities in favor of new, reactive functions. While these functions, including orchestrating immune responses, altering metabolism, and forming astroglial borders, have been increasingly characterized, mechanisms to control or therapeutically modulate these processes remain poorly understood.This thesis has addressed critical gaps in our understanding of how material properties can be used to regulate glial adaptive reprogramming to enhance neural tissue repair and device integration in both CNS injury and implantation contexts. The overarching goal of this work was to design, synthesize, characterize, and implement bioactive, glycan-based materials with tunable chemical, mechanical, and structural properties to dissect the mechanisms of adaptive reprogramming in CNS injury and foreign body response models. Investigation of this knowledge gap led to the development and assessment of three unique biomaterial systems, including: (1) glycan-co-nucleoside hydrogels, which, when tested in models of ischemic stroke, led to enhanced glial-based, neural repair outcomes; (2) thioether-functionalized cellulose coating and films that were oxidation-responsive, tough, biocompatible, and antifouling. Testing in subcutaneous implant models resulted in minimal fibrosis and foreign body response; (3) a RiboTag AAV-loaded biomaterial that enabled astrocyte-border specific transcriptomics. Implementation of this material-enhanced transcriptomic strategy allowed for characterization of reactive astrocytes across time and following drug delivery. This work highlights how the rational design of biomaterials can be used to create tools to dissect and therapeutically manipulate glial adaptive reprogramming. The biomaterial platforms developed in this thesis elucidate structure-function correlations that govern glial reactivity and can serve as a foundation for engineering biomaterials with translational potential for CNS injury repair and neural implant integration.
Degree
thesis:*- Name thesis:degree_name
- Doctor of Philosophy
- Level thesis:degree_level
- doctoral
- Discipline thesis:degree_discipline
- Biomedical Engineering
- Grantor
- Boston University
- Year dc:date.issued
- 2026
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- DuBois, Eric Michael
- Advisor dc:contributor.advisor
-
- O’Shea, Timothy M.
- ORCID dc:identifier.orcid
Subjects
dc:subject × 7Rights
dc:rights- Statement dc:rights
-
- Attribution 4.0 International
- Licence dc:rights.uri
- Language dc:language.iso
- en_US
Identifiers
dc:identifier.*- Handle dc:identifier.uri
- https://hdl.handle.net/2144/52989